| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |